Athersys Inc.

1.72+0.0350+2.08%Vol 2.16M1Y Perf -44.84%
Apr 15th, 2021 16:00 DELAYED
BID1.71 ASK1.72
Open1.72 Previous Close1.69
Pre-Market1.70 After-Market-
 -0.02 -1.13%  - -
Target Price
5.33 
Analyst Rating
Strong Buy 1.50
Potential %
209.88 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-13 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/-5 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-7 
Income Ranking
 —    -
Market Cap370.22M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
10.22 
Earnings Date
6th May 2021

Today's Price Range

1.661.74

52W Range

1.533.39

5 Year PE Ratio Range

-6.40-10.30

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Strong Sell
Performance
1 Week
-3.37%
1 Month
-14.43%
3 Months
-10.42%
6 Months
-8.02%
1 Year
-44.84%
3 Years
-11.34%
5 Years
-28.93%
10 Years
-40.69%

TickerPriceChg.Chg.%
ATHX1.720.03502.08
AAPL134.502.47001.87
GOOG2 296.6641.82001.85
MSFT259.503.91001.53
XOM56.98-0.3400-0.59
WFC42.240.25000.60
JNJ160.390.47000.29
FB307.825.00001.65
GE13.55-0.1300-0.95
JPM152.170.96000.63
ProfitabilityValueIndustryS&P 500US Markets
-
-5 439.70
-5 377.90
-1 463.90
-
RevenueValueIndustryS&P 500US Markets
1.44M
0.01
-32.65
-36.85
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.09-0.11-22.22
Q03 2020-0.08-0.11-37.50
Q02 2020-0.08-0.10-25.00
Q01 2020-0.08-0.10-25.00
Q04 2019--0.06-
Q03 2019-0.08-0.080.00
Q02 2019--0.06-
Q01 2019--0.09-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.08-60.00Negative
6/2021 QR-0.050.00-
12/2021 FY-0.3412.82Positive
12/2022 FY0.21-81.90Negative
Next Report Date6th May 2021
Estimated EPS Next Report-0.08
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume2.16M
Shares Outstanding215.25M
Trades Count7.22K
Dollar Volume6.00M
Avg. Volume3.10M
Avg. Weekly Volume2.21M
Avg. Monthly Volume3.00M
Avg. Quarterly Volume3.26M

Athersys Inc. (NASDAQ: ATHX) stock closed at 1.72 per share at the end of the most recent trading day (a 2.08% change compared to the prior day closing price) with a volume of 2.17M shares and market capitalization of 370.22M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Athersys Inc. CEO is William Lehmann.

The one-year performance of Athersys Inc. stock is -44.84%, while year-to-date (YTD) performance is -1.71%. ATHX stock has a five-year performance of -28.93%. Its 52-week range is between 1.53 and 3.39, which gives ATHX stock a 52-week price range ratio of 10.22%

Athersys Inc. currently has a PE ratio of -4.50, a price-to-book (PB) ratio of 13.11, a price-to-sale (PS) ratio of 260.09, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -149.92%, a ROC of -186.84% and a ROE of -277.84%. The company’s profit margin is -%, its EBITDA margin is -5 377.90%, and its revenue ttm is $1.44 Million , which makes it $0.01 revenue per share.

Of the last four earnings reports from Athersys Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. Athersys Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Athersys Inc. is Strong Buy (1.5), with a target price of $5.33, which is +209.88% compared to the current price. The earnings rating for Athersys Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Athersys Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Athersys Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 28.88, ATR14 : 0.17, CCI20 : -57.44, Chaikin Money Flow : -0.01, MACD : -0.15, Money Flow Index : 45.50, ROC : 6.83, RSI : 38.40, STOCH (14,3) : 38.10, STOCH RSI : 0.74, UO : 46.03, Williams %R : -61.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Athersys Inc. in the last 12-months were: John J. Harrington (Sold 20 000 shares of value $41 709 ), Kenneth H. Traub (Buy at a value of $369 000), Laura K. Campbell (Sold 20 000 shares of value $38 871 ), William Lehmann (Sold 145 000 shares of value $324 471 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (100.00 %)
Moderate Buy
1 (50.00 %)
1 (50.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.00

Athersys Inc.

Athersys Inc is a clinical-stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is a significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

CEO: William Lehmann

Telephone: +1 216 431-9900

Address: 3201 Carnegie Avenue, Cleveland 44115-2634, OH, US

Number of employees: 83

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

47%53%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

News

Stocktwits